You are here

gastroesophageal cancer

Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says

MedPage Today

Tue, 09/24/24 - 09:54 pm

gastroesophageal cancer

ESMO: Jazz HER2 bispecific posts 59% survival at 30 months in gastric cancer

Fierce Biotech

Mon, 09/16/24 - 09:50 am

gastroesophageal cancer

ALX Oncology’s evorpacept shows potential in Phase II gastric cancer trial

Clinical Trials Arena

Thu, 08/1/24 - 11:12 am

clinical trials

gastroesophageal cancer

Bristol Myers' Opdivo leads the pack with FDA approval for resected esophageal or GEJ cancer

Endpoints

Fri, 05/21/21 - 11:48 am

Bristol Myers Squibb

esophageal cancer

gastroesophageal cancer

FDA grants priority review to KEYTRUDA for treatment of esophageal and gastroesophageal junction cancer

Pharmaceutical Business Review

Fri, 12/18/20 - 10:50 am

esophageal cancer

gastroesophageal cancer

Astellas furthers oncology focus with Ganymed buy

BioPharma Dive

Fri, 10/28/16 - 05:48 pm

gastroesophageal cancer

Merrimack Progresses with MM-111

Yahoo/Zacks

Sat, 07/27/13 - 11:13 am

Merrimack Pharmaceuticals

esophageal cancer

gastroesophageal cancer